New Delhi, Dec 7, Dec. 7 -- British-Swedish pharmaceutical firm AstraZeneca on Monday announced a a partnership with Mumbai-based Qure.ai, a healthcare startup to integrate innovative artificial intelligence (AI) solutions for the early detection of lung cancer in patients across India.

AstraZeneca and Qure.ai will be covering the emerging market regions in Latin America, Asia, Middle East and Africa.

The partnership aims to harness and scale-up the use of this technology to improve early-stage detection of lung cancer in the markets involved, to reduce mortality rates and improve patient outcomes.

As part of the strategic collaboration, AstraZeneca will work with Qure.ai to explore the application of deep learning algorithms to identi...